-
×
Kisspeptin-10 10mg & 5mg (Kp-10) (5mg Vial)
1 × $50.00 -
×
Selank
1 × $35.00
Subtotal: $85.00
Semax
$36.00
A synthetic heptapeptide analog of the ACTH(4-10) fragment, stabilized by a C-terminal Pro-Gly-Pro motif, supplied as 10 mg of sterile lyophilized powder for in-vitro neuropharmacology research.
Tested by Freedom Diagnostics TestingHPLC purity + LC-MS identityLot-matched COA on-site
For research use only. This product is a laboratory research chemical. It is not for human or veterinary use, not a drug, supplement, or food, and not intended to diagnose, treat, cure, or prevent any disease. Sold only to qualified researchers and institutions.
What is Semax?
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) analog of the ACTH(4-10) fragment, stabilized by a C-terminal Pro-Gly-Pro motif that confers resistance to enzymatic degradation. Originally developed in Russia, it is studied as a neurotrophic and nootropic research peptide and lacks the steroidogenic and melanocortin activity of full ACTH, isolating the neurotropic activity of the (4-10) fragment as a research tool.
Research areas where laboratories buy Semax for in vitro work include brain-derived neurotrophic factor (BDNF) and TrkB expression studies in hippocampal and basal-forebrain cultures, cerebral ischemia and stroke neuroprotection models in rodents, learning, memory and attention behavioral models, dopaminergic and serotonergic neurotransmission assays, and oxidative-stress and neuroinflammation models in cell culture. Semax is not approved for therapeutic use in the United States or European Union.
Every lot, independently verified
Independently third-party tested and matched to the lot ID printed on your vial. Values below are from the latest released lot.
98.96%
HPLC-UV Purity
Passed full QC panel
independent third-party lab (Freedom Diagnostics Testing) accredited lab
Latest batch · tested 5 Apr 2026 · Freedom Diagnostics (USA)
Lot details
ProductSemax 11 mg
Lot42206SM
AppearanceWhite lyophilized powder
Accession #2604030181
Reported5 Apr 2026
Full QC panel · ISO 170257 assays
Purity (HPLC-UV)98.957% ✓
Identity (LC-MS)Semax ✓
HPLC conformity (2×)Confirmed ✓
Net content11.80 mg ✓
Heavy metals (ICP-MS)Not Detected ✓
SterilityNo Growth ✓
Endotoxin (USP <85>)Within limits ✓
Every lot is released against Koi’s full QC panel — HPLC purity, LC-MS identity, net content, heavy metals, sterility, and endotoxin — by an independent ISO/IEC 17025-accredited laboratory. Values shown are from the latest released lot (Lot 42206SM, reported 5 Apr 2026) and vary batch to batch; the lot-specific certificate is published in our public COA library and matched to the lot ID printed on the vial.
Compound information
Chemical & structural reference data — specifications, molecular profile and handling.
Product Specifications
CompoundSemax (synthetic ACTH(4-10) heptapeptide analog)
Vial size11 mg
Purity≥98% by HPLC
Identity confirmationMass spectrometry
FormWhite lyophilized powder
Appearance after reconstitutionClear, colorless solution
ManufacturingSynthesized and lyophilized in the United States
Quality testingIndependent independent third-party laboratory release
Molecular Profile
SequenceMet-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
Molecular formulaC39H54N10O10S
Molecular weight813.97 g/mol
CAS number80714-61-0
PubChem CID9811062
ParentACTH(4-10) fragment
Structure classSynthetic heptapeptide · Pro-Gly-Pro stabilized
Storage & Handling
AppearanceWhite lyophilized powder
SolubilitySterile water · neutral pH
Storage · powder−20 °C, desiccated, dark (−80 °C long-term)
In solution2–8 °C; aliquot & freeze, avoid freeze-thaw
Semax Mechanism of Action
- Acts as a stable analog of the ACTH(4-10) fragment — the C-terminal Pro-Gly-Pro motif confers resistance to enzymatic degradation, extending activity relative to the native fragment.
- Upregulates brain-derived neurotrophic factor (BDNF) and its receptor TrkB in hippocampal tissue in rodent and cell-culture models.
- Modulates dopaminergic and serotonergic neurotransmission, the basis for much of the published neuropharmacology work.
- Inhibits enkephalin-degrading enzymes, prolonging the activity of endogenous regulatory peptides.
- Engages antioxidant and anti-inflammatory networks in models of cerebral ischemia and oxidative stress.
- Lacks the steroidogenic / melanocortin activity of full ACTH, isolating the neurotropic activity of the (4-10) fragment as a research tool.
Semax Research Applications
- BDNF and TrkB expression studies in hippocampal and basal-forebrain cultures.
- Cerebral ischemia and stroke rodent models examining neuroprotection endpoints.
- Learning, memory, and attention behavioral models in rodents.
- Dopaminergic and serotonergic neurotransmission assays.
- Oxidative-stress and neuroinflammation models in cell culture.
- Enzymatic-stability and structure-activity studies of the Pro-Gly-Pro–stabilized heptapeptide.
Why Buy Semax from Koi Peptides?
- Every batch of Koi Semax is synthesized and lyophilized in the United States, then released against independent third-party laboratory (Freedom Diagnostics Testing) testing.
- Each lot is tested by HPLC for purity, LC-MS for identity confirmation, and endotoxin assay for sterility readiness.
- The lot ID is printed on every vial and ties back to a public COA library, so researchers can verify documentation before they buy and after the vial arrives.
- Orders placed before 2 PM CT ship the same business day, and shipping is free on orders over $200.
- Medvedeva, E. V., et al. (2014). Semax, an ACTH(4-10) analogue, activates dopaminergic and serotoninergic brain systems. Biochemistry (Moscow), 79(3), 209–216. doi.org/10.1134/S0006297914030092
- Dolotov, O. V., et al. (2006). Semax, an analog of ACTH(4-10), stimulates expression of BDNF and trkB in rat basal forebrain. Neuroscience Letters, 396(2), 163–167.
- Shadrina, M. I., et al. (2010). Rapid induction of neurotrophin mRNAs by the neuropeptide Semax. Neuroscience Letters, 471(1), 37–41.
- Storozhevykh, T. P., et al. (2007). Semax and oxidative-stress protection in neuronal cultures. Journal of Molecular Neuroscience, 32(3), 247–253.
- Ashmarin, I. P., et al. (1997). Semax: nootropic and neuroprotective properties of an ACTH(4-10) analog. Neuroscience and Behavioral Physiology, 27(4), 420–424.
Regulatory Status
FDA, WADA anti-doping, and compounding status — provided for research context.
FDA StatusSemax is not approved by the U.S. Food and Drug Administration for any indication. It was developed in Russia, where it is marketed as a nasal-drop preparation, but it has never been approved as a drug in the United States or the European Union. The research-grade material supplied by Koi Peptides is synthesized independently for in vitro laboratory research only — not formulated, packaged, or labeled for human use, not equivalent to any approved drug product, and not authorized for any human or veterinary indication.
WADA Anti-Doping StatusSemax is not named on the WADA 2026 Prohibited List and is not currently classified as a prohibited substance in sport. As with any research compound, athletes who are subject to anti-doping testing should consult the current WADA Prohibited List and their anti-doping authority before use, and should maintain documentation for any approved medical use.
Compounding Pharmacy StatusKoi Peptides is a chemical research supplier — not a compounding pharmacy or outsourcing facility under sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act — and supplies no compounded preparations of any kind. Because Semax is an unapproved substance in the United States, it is not eligible for pharmacy compounding for human use.
Disclaimer
For research use only. Not for human or veterinary use. Semax is supplied to qualified research professionals for in vitro laboratory study. It has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. Koi Research Labs LLC is a chemical supplier, not a compounding pharmacy under 503A nor an outsourcing facility under 503B of the Federal Food, Drug, and Cosmetic Act. By purchasing, the buyer agrees this material will not be introduced into humans or animals. Misuse may violate federal, state, or local laws.
Be the first to review “Semax”
Related products
Reviews
There are no reviews yet.